Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer.
van Baardwijk A, Wanders S, Boersma L, Borger J, Ollers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Lunde R, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: borger j. J Clin Oncol. 2010 Mar 10;28(8):1380-6. doi: 10.1200/JCO.2009.24.7221. Epub 2010 Feb 8. J Clin Oncol. 2010. PMID: 20142596
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.
Aerts HJ, van Baardwijk AA, Petit SF, Offermann C, Loon Jv, Houben R, Dingemans AM, Wanders R, Boersma L, Borger J, Bootsma G, Geraedts W, Pitz C, Simons J, Wouters BG, Oellers M, Lambin P, Bosmans G, Dekker AL, De Ruysscher D. Aerts HJ, et al. Among authors: borger j. Radiother Oncol. 2009 Jun;91(3):386-92. doi: 10.1016/j.radonc.2009.03.006. Epub 2009 Mar 28. Radiother Oncol. 2009. PMID: 19329207 Free PMC article.
Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study.
De Ruysscher D, Dehing C, Bentzen SM, Houben R, Dekker A, Wanders R, Borger J, Hochstenbag M, Boersma L, Geskes G, Dingemans AM, Bootsma G, Lammering G, Lambin P. De Ruysscher D, et al. Among authors: borger j. Radiother Oncol. 2009 Dec;93(3):389-95. doi: 10.1016/j.radonc.2009.06.004. Epub 2009 Jul 1. Radiother Oncol. 2009. PMID: 19576645 Review.
Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.
Wanders R, Steevens J, Botterweck A, Dingemans AM, Reymen B, Baardwijk Av, Borger J, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, De Ruysscher D. Wanders R, et al. Among authors: borger j. Eur J Cancer. 2011 Dec;47(18):2691-7. doi: 10.1016/j.ejca.2011.06.023. Epub 2011 Jul 4. Eur J Cancer. 2011. PMID: 21733675 Free article.
Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study.
De Ruysscher D, van Baardwijk A, Steevens J, Botterweck A, Bosmans G, Reymen B, Wanders R, Borger J, Dingemans AM, Bootsma G, Pitz C, Lunde R, Geraedts W, Oellers M, Dekker A, Lambin P. De Ruysscher D, et al. Among authors: borger j. Radiother Oncol. 2012 Feb;102(2):228-33. doi: 10.1016/j.radonc.2011.10.010. Epub 2011 Nov 17. Radiother Oncol. 2012. PMID: 22100659
Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer.
van Baardwijk A, Reymen B, Wanders S, Borger J, Ollers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Lunde R, Peters F, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: borger j. Eur J Cancer. 2012 Oct;48(15):2339-46. doi: 10.1016/j.ejca.2012.04.014. Epub 2012 May 18. Eur J Cancer. 2012. PMID: 22608261 Clinical Trial.
Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.
Reymen B, Van Loon J, van Baardwijk A, Wanders R, Borger J, Dingemans AM, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, De Ruysscher D. Reymen B, et al. Among authors: borger j. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1319-24. doi: 10.1016/j.ijrobp.2012.10.003. Epub 2012 Nov 29. Int J Radiat Oncol Biol Phys. 2013. PMID: 23200174
Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR).
Reymen B, van Baardwijk A, Wanders R, Borger J, Dingemans AM, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, De Ruysscher D. Reymen B, et al. Among authors: borger j. Radiother Oncol. 2014 Mar;110(3):482-7. doi: 10.1016/j.radonc.2013.12.005. Epub 2014 Jan 17. Radiother Oncol. 2014. PMID: 24444527
18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
van Loon J, Offermann C, Bosmans G, Wanders R, Dekker A, Borger J, Oellers M, Dingemans AM, van Baardwijk A, Teule J, Snoep G, Hochstenbag M, Houben R, Lambin P, De Ruysscher D. van Loon J, et al. Among authors: borger j. Radiother Oncol. 2008 Apr;87(1):49-54. doi: 10.1016/j.radonc.2008.02.019. Epub 2008 Mar 14. Radiother Oncol. 2008. PMID: 18342967
Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.
De Ruysscher D, Dehing C, Yu S, Wanders R, Ollers M, Dingemans AM, Bootsma G, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Borger J, Dekker A, Lambin P. De Ruysscher D, et al. Among authors: borger j. Radiother Oncol. 2009 Jun;91(3):353-9. doi: 10.1016/j.radonc.2008.10.006. Epub 2008 Nov 13. Radiother Oncol. 2009. PMID: 19012981
178 results